1 / 18

Early versus Delayed Treatment in Patients with Recent-onset Rheumatoid Arthritis: Comparison of Two Cohorts Who Receive

Early versus Delayed Treatment in Patients with Recent-onset Rheumatoid Arthritis: Comparison of Two Cohorts Who Received Different Treatment Strategies.

Rita
Download Presentation

Early versus Delayed Treatment in Patients with Recent-onset Rheumatoid Arthritis: Comparison of Two Cohorts Who Receive

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Early versus Delayed Treatment in Patients with Recent-onset Rheumatoid Arthritis: Comparison of Two Cohorts Who Received Different Treatment Strategies Lard, L., H. Visser, I. Speyer, I. vander Horst-Bruinsma, A. Zwinderman, F. Breedveld, J. Hazes. 2001. American Journal of Medicine. October: 111(6): 446-451. Presented by Wislaine Coby

  2. What is rheumatoid arthritis? • An autoimmune disease that causes chronic inflammation of the joints. • Two million Americans are affected of all ages. • Most common in women

  3. Cause • The cause is not known • Suspicions of infectious agents such as viruses and bacteria but no proof as the cause. • May be genetically inherited

  4. Signs and Symptoms • Stiffness • Pain • Swelling • Redness • Fatigue

  5. Normal and Arthritic Joint

  6. Diagnosis of Definite or Probable RA • Morning stiffness for more the 30 minutes • More than five swollen joints • Ritchie score greater than 15 • Erythrocyte sedimentation rate greater than 28 mm/h

  7. Other Requirements • Radiographic joint damage, measured by modified Sharp score • Health assessment questionnaire • Modified disease activity score • C-reactive protein level

  8. Treatment Strategies • (DMARD) disease modifying antirheumatic drug=helps to slow the progression of the disease • (NSAID) nonsteroidal anti-inflammatory drugs=reduces pain and inflammation. Early treatment:(DMARD) disease modifying antirheumatic drug and (NSAID) nonsteroidal anti-inflammatory drugs (two weeks after) Delayed treatment:(NSAID) nonsteroidal anti-inflammatory drugs and (DMARD) disease modifying antirheumatic drug (used after several months)

  9. Prescribed dose on type of DMARD • Chloroquine: 300 mg/day for the first month • Salazopyrine: 2000 mg/day

  10. Results of study • From 1993 of January to 1995 of December, 109 patients with probable or definite disease were included. • From 1996 of January – 1998 of December, 97 patients with arthritis were included.

  11. Characteristics of the two groups

  12. Chart Analysis • Patients in the early treatment group showed very little progression of joint destruction

  13. Treatment with dmd

  14. Modified Sharp Score • Progression of radiographic joint damage was the same at 6 months for both group. • Early: stabilized at 3.5 • Delayed: progressed at 10

  15. Median Disease Activity Score/C-reactive Protein Level •Early treatment showed greater improvement for the mdas; •Low levels in the Crpl (322) and the mdas (64) •Delayed had high levels in the Crpl (486) and mdas (73) C-reactive Protein Level

  16. Side Effects Delayed • 3patients had to change initial therapy due to side effects • First treatment changed because lack of efficacy in 10 patients. • 4 patients changed initial therapy without dmard Early • 12 patients changed treatment due to adverse affects • 21 patients discontinued treatment due to lack of efficacy. • 8 patients changed initial therapy without dmard

  17. Conclusion • Early treatment is crucial to reduce any symptoms, maximize joint function and prevent joint destruction and deformity. • DMAD has very little side effects and is a better drug to treat patients with early RA.

  18. QUESTIONS

More Related